Dr. Robert William Levin, MD

Dr. Levin practices at American Arthritis & Rheumatology Associates in Boca Raton, Florida.

Dr. Levin's NPI, 1326066903, was assigned on July 18, 2006. Dr. Levin graduated from Drexel University College Of Medicine in 1984. Dr. Levin holds Florida license ME55316.

Dr. Levin's primary practice is American Arthritis & Rheumatology Associates, at 2255 W Glades Rd, Boca Raton, FL 33431 in Palm Beach County. The practice phone is (561) 747-1987.

Dr. Levin's primary practice is American Arthritis & Rheumatology Associates in Boca Raton, Florida. Dr. Levin is also affiliated with BayCare St. Joseph's Hospital. The medical group on file is AARA (The American Arthritis and Rheumatology Associates). Dmand AI also links Dr. Levin to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Levin practices, 4 sites in all. Vendor and product names are available with a free account.

Rheumatology is Dr. Levin's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dr. Levin is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Levin's licenses on file in 2 states: Florida and Pennsylvania.

Dmand AI lists arteritis, arthritis, gout, joint pain, lupus, muscle pain, fibromyalgia, and limb pain, osteoporosis and rheumatoid arthritis among the conditions Dr. Levin treats.

CMS data shows 134,099 Medicare services from Dr. Levin across 21 procedure codes in 2024, for 400 Medicare patients. Medicare paid $1,704,314 for them. Every service was in an office.

CMS counts 400 Medicare patients who saw Dr. Levin in 2024. The largest group is 65 to 74, with 166 patients. 75% of them have arthritis, and 75% have high cholesterol. 4% are also on Medicaid. Their average risk score is 1.58, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Levin's median patient age at 72, with 78% women.

In 2024, Dr. Levin wrote 3,405 Medicare Part D claims for 546 patients. 89% of them were for generic drugs. CMS names the drug for 3,097 of them, across 57 drugs with 11 or more claims each, at $1,234,546 in total drug cost. In 2023, CMS named 2,959 claims across 58 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Levin for performance year 2024, reported as part of a group. Dr. Levin accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 5 papers to Dr. Levin, published from 2011 to 2024. The most frequent topics are Double-Blind Method and Lupus Erythematosus, Systemic. Dr. Levin's most frequent co-authors are Vishala Chindalore, MD, Shervin Assassi, MD and Seth Mark Berney, MD.

Dmand AI links Dr. Levin to 12 clinical trials, 2 of them phase 1 studies. 2 are still active or recruiting. Conditions studied include Connective Tissue Diseases, Lupus Erythematosus, Systemic and Rheumatic Diseases. Eli Lilly and Company sponsors the most, 4. Open Payments lists research payments to Dr. Levin that name 3 trials.

CMS Open Payments shows 2,234 general payments to Dr. Levin from 46 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 53% of the total. Abbvie Inc. paid the most, $169,630. It also lists 48 research payments totaling $336,712 from 2016 to 2023, naming 3 clinical trials.

Dr. Levin graduated from Drexel University College Of Medicine in 1984.

Dr. Levin is in network with 19 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.